CUV 1.71% $14.84 clinuvel pharmaceuticals limited

Ann: CLINUVEL withdraws label expansion for adolescent EPP, page-4

  1. 476 Posts.
    lightbulb Created with Sketch. 93
    Still providing doses to existing patients and they believe it is only a minor delay. My guess is this is why it is not market sensitive.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.